Kardiologia polska · 2026
Impact of smoking on outcomes in patients with myocardial infarction with non-obstructive coronary arteries - an observational study.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Koźlik Maciej, Desperak Aneta, Bujak Marta, Ćmiel Ania, Pluta Maja, Gierlotka Marek, Wita Krystian, Kalarus Zbigniew, Buszman Paweł, Piegza Jacek, Mamas Mamas, Wittek Piotr, Wojakowski Wojciech, Gąsior Paweł
Аннотация
BACKGROUND: The pathomechanism of myocardial infarction with non-obstructive coronary arteries (MINOCA) is diverse and not fully explained. One of the factors for cardiovascular risk evaluation is smoking. Nevertheless, "smoker's paradox" is a controversial phenomenon in patients with myocardial infarction, which can imply better outcomes in smokers than non-smokers.
AIMS: This study aimed to assess the association between smoking and clinical outcomes in MINOCA patients.
METHODS: In this study 6045 patients hospitalized with a working diagnosis of MINOCA were evaluated, of whom 4808 (79.5%) were non-smokers. Our analysis included baseline characteristics, outcomes, and readmission rates during a 36‑month follow‑up.
RESULTS: Smoking patients were significantly younger (59 [52-66] vs. 70 [60-78] years; P <0.001) than non-smokers. There were more male patients in the smoking (64.92% vs. 40.95%) than in the non-smoking group. Smokers were less likely to have traditional risk factors, more frequently had symptoms of angina (89.29% vs. 86.87%; P = 0.03), and had lower mortality during hospitalization (0.81% vs. 1.75%; P = 0.02), after 12 months (8.08% vs. 11.69%; P <0.001) and after 36 months (13.34% vs. 16.95%; P = 0.002), as compared with non-smokers. Nevertheless, multivariable analysis showed that smoking was one of the independent risk factors for 36‑month mortality (hazard ratio, 1.23;95% confidence interval, 1.03-1.47; P = 0.02).
CONCLUSIONS: This study showed that lower 36‑month crude rates of death among smokers (comparing to non-smokers) may be explained by a significantly lower burden of traditional risk factors and the younger age of smokers. After adjusting for baseline differences, tobacco use remained an independent risk factor for 36‑month mortality.
AIMS: This study aimed to assess the association between smoking and clinical outcomes in MINOCA patients.
METHODS: In this study 6045 patients hospitalized with a working diagnosis of MINOCA were evaluated, of whom 4808 (79.5%) were non-smokers. Our analysis included baseline characteristics, outcomes, and readmission rates during a 36‑month follow‑up.
RESULTS: Smoking patients were significantly younger (59 [52-66] vs. 70 [60-78] years; P <0.001) than non-smokers. There were more male patients in the smoking (64.92% vs. 40.95%) than in the non-smoking group. Smokers were less likely to have traditional risk factors, more frequently had symptoms of angina (89.29% vs. 86.87%; P = 0.03), and had lower mortality during hospitalization (0.81% vs. 1.75%; P = 0.02), after 12 months (8.08% vs. 11.69%; P <0.001) and after 36 months (13.34% vs. 16.95%; P = 0.002), as compared with non-smokers. Nevertheless, multivariable analysis showed that smoking was one of the independent risk factors for 36‑month mortality (hazard ratio, 1.23;95% confidence interval, 1.03-1.47; P = 0.02).
CONCLUSIONS: This study showed that lower 36‑month crude rates of death among smokers (comparing to non-smokers) may be explained by a significantly lower burden of traditional risk factors and the younger age of smokers. After adjusting for baseline differences, tobacco use remained an independent risk factor for 36‑month mortality.